CLINICAL TRIAL

Measurement of Persisting Changes in Emotional Brain Functioning Produced by Psilocybin

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: ClinicalTrials.gov
Date: 2019-09-10
Source: ClinicalTrials.gov
DOI: Unavailable
PubMed: Unavailable

Authors

Johns Hopkins University

Watch author

Derived topics and classifications

psilocybin Mechanism of Action Emotional Processing Abuse Liability Other

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-facilitated Smoking Cessation Treatment: A Pilot StudyClinicalTrials.gov · 2025-05-25 Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14 Open Label Psilocybin Brain Stimulation and Imaging Pilot StudyClinicalTrials.gov · 2026-08-07 Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-25 Precision Functional Brain Mapping to Understand the Mechanisms of PsilocybinClinicalTrials.gov · 2025-10-31 Modulation of Serotonin Pathways Using Psilocybin in Adults With and Without Autism Spectrum Disorder (ASD)ClinicalTrials.gov · 2025-07-28 Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in ReligionClinicalTrials.gov · 2024-06-18 Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use DisorderClinicalTrials.gov · 2023-09-21